Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
09/2004
09/16/2004US20040180953 B form is the most thermodynamically stable form at room temperature; a purer and more homogeneous product is produced and recrystallization is advantageously carried out by initiating with a small amount of the product
09/16/2004US20040180940 Substituted anilide ligands for the thyroid receptor
09/16/2004US20040180930 excellent suppressing effect to cell injury caused by radicals and neurotoxicity induced by excitatory nuerotransmitters such as glutamate
09/15/2004EP1457482A1 Stable isotope-labeled amino acid, method of integrating the same into target protein, method of nmr structural analysis of protein and process for producing site-selective stable isotope-labeled fumaric acid and tartaric acid
09/15/2004EP1455773A1 2-aryl-propionic acids and pharmaceutical compositions containing them
09/15/2004EP1224161B1 Nitroxy derivatives of (r) and (s)-carnitine
09/15/2004EP1077925B1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
09/15/2004CN1529694A Method for preparing
09/15/2004CN1529691A N-Benzyl-M-Phenylenedimine derivatives and dyes containing said compounds
09/15/2004CN1529685A Improved metal-ligand complex catalyzed processes
09/15/2004CN1528754A Beta-hydroxy-alpha-amino acid and its derivatives and synthesizing method for preparing template
09/15/2004CN1528752A Oxazolidine intermediate for preparing taxad alkane
09/15/2004CN1528739A Levodopa methyl ester hydrochloride purifying method
09/15/2004CN1166625C Green synthesis process of betaine hydrochloride
09/15/2004CN1166443C Betaine product, method for its manufacture, and its use
09/14/2004US6790986 Forming a water insoluble hydroxybenzoic acid salt in aqueous solution, precipitation, suspension in a lower alcohol, adding a tertiary amine base to precipitate pure gabapentin; free of chloride anions
09/14/2004US6790964 Process for the preparation of 7-azabicyclo[4.1.0]hept-3-ene-3-carboxylic acid esters
09/14/2004US6790865 2-methylpropionic acid derivatives and pharmaceutical compositions comprising the same
09/10/2004WO2004075889A1 Process for preparation of perindopril and salts thereof
09/10/2004WO2004052837A3 Amino substituted hydroxyphenyl benzophenone derivatives
09/10/2004WO2004043392B1 Mucin synthesis inhibitors
09/10/2004WO2004016260A8 Therapeutic use of fused bicyclic or tricyclic amino acids
09/10/2004WO2004009034A3 Thiomolybdate analogues and uses thereof
09/09/2004US20040176639 Process for the preparation of pure gabapentin "Form II"
09/09/2004US20040176637 Process for preparation of 2-chlorophenylglycine derivatives and enantiomerically separation
09/09/2004US20040176460 Use of L-(+)-tartaric acid in the separation of (R, R)-3-phenylisoserine or a derivative thereof from racemic mixtures
09/09/2004US20040176446 Substituted amino dicarboxylic acid derivatives
09/09/2004US20040176445 Propionic acid derivatives
09/09/2004US20040176425 Cycloalkyl containing anilide ligands for the thyroid receptor
09/08/2004EP1454896A1 Amine, amide, sulfonamide and carbamate derivatives of benzylidenemalonoc acid salts photoprotective cosmetic compositions containing them
09/08/2004EP1453843A2 Powder trace element, method and device for making same
09/08/2004EP1453791A1 Acetyl l-carnitine salt with a dicarboxilic organic acid and process for preparing same
09/08/2004EP1453777A1 Functionalized higher diamondoids
09/08/2004EP1082291B1 Chemical process for the stereoselective synthesis of r-(-)-carnitine
09/08/2004CN1527811A Process for the preparation of (R)-or (S)-aminocarnitine inner salt, the salts and derivatives thereof
09/08/2004CN1526698A Production process of high-purity DL-lysine
09/08/2004CN1165518C Biocyclic amino acids compound compound as pharmaceutical agents
09/07/2004US6787664 Radical deoxygenation of tertiary hydroxy group
09/07/2004US6787570 Administering an aromatic or heteroaromatic substituted tertiaryamine compound to treat atherosclerosis, dyslipidemia, and other coronary artery diseases
09/07/2004US6787562 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists
09/02/2004WO2004074255A2 Method for producing an optically active tetrahydroquinoline
09/02/2004WO2004074216A2 Carnitine salt, preliposome which contains it and dermo-cosmetic formula for topical use based upon said carnitine salt
09/02/2004US20040171877 Anticaking agents
09/02/2004US20040171876 Processes for the production of alpha-difluoromethyl ornithine (DFMO)
09/02/2004US20040171875 Process for the preparation of (r)- or (s)-aminocarnitine inner salt, the salts and derivatives thereof
09/02/2004US20040171833 Ligands for metals and improved metal-catalyzed processes based thereon
09/02/2004US20040171572 Complex cationic lipids having quaternary nitrogens therein
09/02/2004US20040171516 Containing substituted aromatic rings
09/01/2004EP1452604A2 Coenzyme useful for the synthesis of L-Carnitine
09/01/2004EP1451147A1 Amino acid derivatives
09/01/2004EP1274675B1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
09/01/2004EP1072583B1 2-methylpropionic acid derivatives and medicinal compositions containing the same
09/01/2004CN1524960A Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
09/01/2004CN1524847A Producing method of of tranexamic acid
09/01/2004CN1524846A Producing process for threonine benzyl ester oxalate
09/01/2004CN1524835A Method for processing asymmetric hydroxylamination and dihydroxylation reaction by use of supported bi-cinchoni alkaloid ligand
09/01/2004CN1164577C Process for preparing 2-amino-4-(4-fluorophenyl)-6-alkylpyrimidine-5-carboxylate
09/01/2004CN1164566C Preparation of ferrous glycinate chelate by metathesis method
09/01/2004CN1164565C Process for preparing amino acids from natural albumen
08/2004
08/31/2004US6784311 Method of producing 3-aminoalkanoic acid esters
08/31/2004US6784304 Use of optionally n-protected 2,2-dialkyl,4-substituted-5-carboxy-oxadiazolidines in the preparation of c-13 acyloxy sidechain-bearing taxanes such as paclitaxel
08/31/2004US6784299 Substituted aromatic ethers as inhibitors of glycine transport
08/31/2004US6784295 Carried out in the presence of an inorganic base or organic nitrogen base and a palladium complex catalyst containing secondary monophosphines with aliphatic, branched or cyclic substituents as ligands
08/31/2004US6784208 Method for preventing and treating visceral pain and gastrointestinal disorders
08/31/2004US6784202 Cubane derivatives as metabotropic glutamate receptor agonists or antagonists and process for their preparation
08/31/2004US6783946 Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
08/31/2004CA2159828C Process to prepare amino-carboxylic acid salts
08/26/2004WO2004072054A1 Method for the production of bicyclic aromatic amino acids and intermediate products thereof
08/26/2004WO2004072017A1 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
08/26/2004WO2004072013A1 Hydroxyeicosadienoic acid compound
08/26/2004WO2004071416A2 Novel inhibitors of formation of advanced glycation endproducts (ages)
08/26/2004WO2004032824A3 Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents
08/26/2004DE10305816A1 Biodegradable alkaline earth metal and heavy metal ion complexing agents, useful e.g. in cleansing or detergent compositions, comprising new or known dialkylene triamine derivatives with aminomethylene moiety
08/26/2004DE10305784A1 3-Oxo-3,4-dihydro-2H-benz-(1,4)-oxazin-6-yl)-propionic acid derivative preparation, for use as integrin inhibitors with e.g. antitumor action, by multi-stage process giving diastereomerically pure product
08/26/2004CA2511900A1 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
08/25/2004EP1449832A1 CRYSTALS OF NON−NATURAL STEREOISOMER SALTS OF MONATIN AND UTILIZATION THEREOF
08/25/2004EP1449824A1 Process for producing erythro-3-amino-2-hydroxybutyric acid derivatives
08/25/2004EP1448757A1 Pro-perfume compositions used in cleaning or fabric treatment products
08/25/2004EP1244645B1 Stereospecific hydrolysis of optically active esters
08/25/2004CN1523019A Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents
08/25/2004CN1523008A Method for manufacturing methionine chromium chelate
08/25/2004CN1163477C Substituted beta-alanine
08/25/2004CN1163473C Synthesis method of L-glutamic acid-5-methyl ester
08/25/2004CN1163472C Novel method for preparing chiral amino acid
08/24/2004US6780998 Substituted 2-aminoalkyl-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same
08/24/2004US6780874 Autoimmune disease; antiinflammatory agents; antiproliferative agent
08/19/2004WO2004056365A3 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
08/19/2004WO2004047751A3 Calcilytic compounds
08/19/2004US20040162442 intermediates in the synthesis of pharmaceutically active protein kinase inhibitors
08/19/2004US20040162434 reacting an organic salt or an organic ester with ammonia or an ammonium salt compound under high-temperature and high-pressure water conditions for synthesizing or manufacturing an amino acid
08/19/2004US20040162433 Lipoxin A4 analogs
08/19/2004US20040162281 Pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents
08/18/2004EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists
08/18/2004EP1144361B1 Method for reducing 3-dimethylamino-2-phenylpropion-acid ethyl ester-content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester
08/18/2004EP1087935B1 Anthracene derivatives as anti-cancer agents
08/18/2004CN1522241A Crystalline form of a phenylethanolamine, preparation thereof and pharmaceutical compositions comprising same
08/18/2004CN1162399C Amino acid-iodine complex
08/18/2004CN1162398C Diammonium ruthenium diethylenetriaminepentaacetate or hydrates thereof and process for the preparation of both
08/18/2004CN1162397C Therapeutically and/or nutritionaly enhanced derivatives of active ingredients and orally administrable compsns. contg. the same
08/18/2004CN1162396C Process for preparing dialkylamino ethanol carboxylate and its salt